Robinson investigates how care models influence incretin therapy outcomes
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
The way clinicians talk about weight can leave lasting impressions, shaping how patients view themselves and engage with healthcare. In weight management care, patients commonly report experiencing…
Over the last four years, the University of Iowa Health Care Weight Management Clinic has made remarkable strides in addressing one of the most pervasive…